Cushing Asset Management, LP Exact Sciences Corp Transaction History

Cushing Asset Management, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $235,595 - $504,337	6,616 Added 179.05%	10,311 $406,000
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $13,699 - $19,644	238 Added 6.88%	3,695 $258,000
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $264,625 - $367,482	-3,650 Reduced 51.36%	3,457 $269,000
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $1,804 - $2,481	20 Added 0.28%	7,107 $678,000
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $13,393 - $19,915	-143 Reduced 1.98%	7,087 $881,000
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $107,943 - $143,539	-926 Reduced 11.35%	7,230 $953,000
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $43,429 - $61,964	-436 Reduced 5.07%	8,156 $1.08 Million
Q3 2020 Nov 16, 2020	BUY	$72.92 - $102.01 $12,979 - $18,157	178 Added 2.12%	8,592 $876,000
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $20,571 - $34,224	369 Added 4.59%	8,414 $732,000
Q1 2020 May 15, 2020	BUY	$37.9 - $104.44 $29,145 - $80,314	769 Added 10.57%	8,045 $467,000
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $12,114 - $15,559	156 Added 2.19%	7,276 $673,000
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $643,434 - $872,128	7,120 New	7,120 $643,000

667

152M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.81B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Cushing Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cushing Asset Management, LP with notifications on news.